The Gamble Behind a Big Takeover of Tylenol’s Maker
Kimberly-Clark’s $40 billion deal for Kenvue, the embattled maker of Tylenol and other consumer products, seemingly flies in the face of two M.&A. maxims: skirt uncertainty whenever possible, and avoi...